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ABSTRACT
Intracellular membrane fusion events can be reconstituted by exploiting isolated organelles from
cellular hosts or artificial membranes made of purified phospholipid components. Artificial
construction of membranes provides two significant advantages. First, cellular isolation of the
endosome-derived vesicles and TGN (trans-Golgi Network) compartments needed for the fusion
assay would be extremely challenging. Second, reconstituting the membranes provides the added
benefit of controlling size and lipid compositions to functionally mimic the individual membrane
architectures and introduce only the purified proteins that are under investigation. For these
reasons, I have developed the first simultaneous lipid and content mixing fusion assays that
measures the efficacy of endosome-to-TGN fusion and its promoted fusion capability with the
dynamin-like protein Vps1 for the purposes of recapitulating the fusion. To quantify lipid mixing
between the donor and recipient membrane fluorescent lipids (Rhodamine-PE and NBD-PE)
were used, while content mixing was assessed by analyzing the increase of FRET between Cy5streptavidin and PhycoE-biotin.
KEYWORDS: Vps1, Tlg2, endosome, TGN, membrane fusion, proteoliposome reconstitution,
simultaneous fusion assay, lipid mixing, content mixing
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INTRODUCTION

Membrane fusion plays an essential role in critical intracellular processes such as
organelle biogenesis, neurotransmission, and hormone secretion, as well as supporting the
various stages of endocytic and exocytic traffic (Wickner & Schekman, 2008). Fusion is initiated
as two opposing membranes are situated in close proximity to one another, followed by the local
distortion of each individual lipid bilayer and their subsequent merger into a single membrane
(Chernomordik & Kozlov, 2008). Various types of membrane fusion events coordinate cellular
activities and are necessary for proper cellular functions. Homotypic vacuolar fusion is critical
for regulating the degradation and recycling of materials needed to control cellular metabolism
(Malia & Ungermann, 2016), while heterotypic endosome-to-Golgi fusion is necessary for
recycling sorting receptors (Progida & Bakke, 2016). The well-characterized SNARE-mediated
{(soluble N-ethylmaleimide–sensitive factor) - attachment protein receptor)} vesicle fusion with
the plasma membrane acts as a central regulator for neurotransmitter release (Südhof & Rizo,
2011).
While specific molecular components differ between the many unique multimeric protein
interactions required for each localized fusion event, target and vesicular SNARE interactions (tSNAREs and v-SNAREs, respectively) generally comprise the central machinery necessary for
fulfilling the proximal requirements to initiate fusion (Han et al, 2017). Associated SNARE
complexes force two individual membranes into proximal arrangements that cause the apposed
bilayers to come into direct contact with one another. It was long speculated that SNARE
proteins alone could drive the entire process of fusion (Weber et al, 1998). While SNARE
interactions are critical for the proximal requirements between two fusing membranes, SNARE

1

assembly alone is insufficient to mediate the entire synaptic fusion cycle (Südhof, 2013a).
Thanks to breakthroughs in in vitro lipid and content mixing analysis using artificial
proteoliposome constructs, the current paradigm surrounding fusion mechanics now incorporates
a host of local protein interactions required for full fusion. The specific proteins involved include
Rab’s and their effector proteins, tethers and adaptors, chaperones, as well as specialized lipids
with fusogenic properties (Wickner & Rizo, 2017). Studies using isolated yeast vacuoles and
reconstituted proteoliposomes carrying florescent lipids in the presence of these protein
components have supported this new paradigm in various in vitro fusion reconstitution assays. In
these assays, it was shown that vacuolar lipid and content mixing, through SNARE activity
alone, was only observed at high SNARE densities far outside normal physiological
concentrations, and fusion at physiological SNARE densities required Rab GTPase Ypt7
imbedded in both fusing membranes (Zick et al, 2015).
Taken together these finding provide strong support for the necessity of a localized
protein network, including SNARES and additional factors, acting synergistically to regulate the
assembly/disassembly cycles during SNARE complex formation and SNARE-mediated fusion.
A unified mechanism uniting the numerous spatiotemporal protein and lipid interactions required
for fusion has yet to be proposed and seems unlikely due to the diverse protein networks and
interactions specific to each precise fusion event. The following is meant to elucidate the
diversity and complexity inherent in various types of membrane fusions by highlighting
similarities and differences, as well as the recent advances specific to each type of fusion
reaction being discussed. The yeast and mammalian SNARE and SM proteins for each type of
fusion reaction are listing in Table 1.
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Synaptic Membrane Fusion
The precision and speed required for neurotransmission is tightly controlled by fusion
events that regulate neurotransmitter release via neuronal exocytosis. During synchronous
release, voltage-gated Ca2+ channels briefly open triggering a localized influx of Ca2+ that binds
to the calcium sensor synaptotagmin-1 at presynaptic active zones inducing Ca2+-triggered fusion
pore opening and content release of neurotransmitter-filled synaptic vesicles to the presynaptic
plasma membrane. (Südhof & Rizo, 2011). Before pore opening and expansion, which represent
later stages of the complete fusion cycle, loaded vesicles must be docked close to cargo release
sites. The specific proteins and molecular mechanisms of this docking step need further
elucidation, but interestingly SNAREs do not appear to be involved in this process. After
docking, synaptic vesicles are primed for fusion via the activation of syntaxin-1 from its closed
conformation to the open Munc18-binding confirmation that promotes the partial assembly of
the trans-SNARE complex (Dawidowski & Cafiso, 2016).
Interactions between the coiled-coil regions of presynaptic membrane SNAREs,
syntaxin-1, SNAP-25, and v-SNARE synaptobrevin form a partially “zippered” conformation
representing the initial fusion intermediate step (Gundersen, 2017). Partial trans-SNARE
complex formation is followed by progressive zippering from the N- to C-terminal of the fourhelical bundle (Südhof & Rothman, 2009). SNARE complex assembly is enhanced by molecular
chaperones (CSPs and synucleins), while disassembly is maintained by N-ethylmaleimidesensitive factor (NSF) and SNAP protein adaptors (a-, b-, or g-SNAP) (Rizo & Xu, 2015;
Söllner et al, 1993). In 2013, the collaborative Nobel Prize winning work of James Rothman,
Randy Schekman, and Thomas Südhof revealed that proper synaptic fusion requires SNAREassociated SM proteins (Sec1/Munc18-like proteins) aided by chaperone complexes, NSF-

3

cysteine string proteins (CSPs) and synucleins, localized to active zones at the site of synapsis
(2013). Results from further studies have supported the necessity of accessory proteins and
demonstrated that SNARE activity alone can drive the hemifusion step, but synaptotagmin
(Syt1) and Ca2+ were required for full fusion and pore expansion during rapid neurotransmitter
release (Lai et al, 2013; Liu et al, 2016).
During hemifusion, only the outer leaflets of each bilayer participate in lipid mixing,
while the inner leaflets remain distinctly separate. Full fusion is marked by the continuation of
lipid mixing through both leaflets and the opening and expansion of a fusion pore, which
facilitate content release and the physical coalescence of the two previously distinct bilayers
(Giraudo et al, 2005). As previously mentioned, assembly chaperones (CSPs and synucleins)
enhance SNARE complex assembly, while the progressive zippering of the trans-SNARE
complex forces the two-apposed bilayers into close proximity resulting in the destabilization of
both membranes around the active fusion site. As the fusion pore expands the trans-SNARE
complex, marked by fusion machinery separately associated with each membrane, converts to a
cis conformation in which the associated SNARE-SM proteins reside on the same merged
membrane (Südhof, 2014; Martens & McMahon, 2008).
A new paradigm proposed by Jose Rizo and William Wickner also focuses on the
necessity of effector proteins bound to the trans-SNARE complex during the later stages of
fusion. These various effectors trigger lipid rearrangement by inserting their apolar domains into
the bilayer completing the last discernable steps of fusion (Wickner & Rizo, 2017). After fusion,
disassembly of the SNARE complex is regulated by the ATPase NSF protein, which binds
SNARE complexes via SNAP protein adaptors. ATP hydrolysis provides the energy for
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disassembly of the subsequent cis-SNARE complex and frees the SNAREs for later rounds of
trans-SNARE associations (Söllner et al, 1993; Wickner & Rizo 2017).

Homotypic Vacuolar Fusion
Vacuolar fusion retains many functional similarities when compared to the previously
mentioned model of synaptic membrane fusion. The most obvious dissimilarity between the two
fusion events is the use of calcium-gated channels mediated by the Ca2+ sensor synaptotagmin to
achieve the precise millisecond precision necessary for rapid neurotransmitter release
(Fernandez-Chacon et al, 2001; Südhof, 2013b). In yeast, vacuolar fusion microdomains, which
were found to be enriched with fusogenic proteins and lipids that facilitate membrane fusion,
include SNAREs, Rab GTPases (Barr, 2013) and their exchange factors, effectors, tethering
complexes, associated SM proteins (Lürick et al, 2016; Baker et al, 2015), and a variety of
fusogenic lipids (Fratti et al, 2004; Mima et al, 2008; Orr et al, 2015; Zick et al, 2015).
Many in vitro reconstitution assays using purified vacuolar membranes and synthetic
proteoliposomes have provided powerful evidence for a multitude of localized proteins, in
addition to SNAREs, necessary for efficient fusion under near physiological conditions (Wickner
& Rizo, 2017; Zick & Wickner, 2016; Baker & Hughson, 2016). During vacuolar homotypic
fusion, the hexameric homotypic fusion and vacuole protein sorting (HOPS) complex acts as a
tether directly binding to Rab/Ypt7 located on apposed membranes. Membrane bound Rab/Ypt7,
a GTPase switch-like protein, is necessary for the proper localization of HOPS to the site of
fusion and requires guanine nucleotide exchange factors (GEFS) for their activation to the GTPbound functional form (Barr, 2013). The HOPS core complex is composed of four subunits
(Vps11, 16, 18, and 33) and two specific Rab binding subunits (Vps41 and Vps39). The latter
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two are located at opposite ends of the complex and are thought to fulfill bridging requirements
by closely positioning each of the apposed membranes’ SNAREs for trans-SNARE complex
formation (Kummel & Ungermann 2014; Brocker et al, 2012).
SNAREs can be categorized as R- (arginine) or Q- (glutamine) based on the central
arginyl or glutaminyl residues located in the heptad-repeat SNARE domains (Fasshauer et al,
1998; Kloepper et al, 2007). The four SNAREs that participate in vacuolar fusion are R-SNARE
Nyv1, Qa-SNARE Vam3, Qb-SNARE Vti1, and Qc-SNARE Vam7. The Qc-SNARE Vam7 is
the only peripheral SNARE that binds to membranes based on affinities for acidic lipids, as well
as HOPS and other SNAREs. The other three SNAREs (R-, Qa, Qb) are membrane anchored by
a C-terminal transmembrane domain (TMD) (Lee et al, 2006; Stroupe et al, 2006; Karunakaran
& Wickner, 2013). The HOPS subunit Vps33 is an SM-like protein with a characteristically
conserved groove that binds R- and Qa-SNAREs (Baker et al, 2015). X-ray structures have
shown Qa-SNARE Vam3 lies in the conserved cleft of Vps33, while R-SNARE Nyv1 binds to a
non-overlapping region outside the cleft. The initial interaction between Vps33 and Vam3 is
thought to bind and facilitate the unfolding of Vam3 at the N-terminus, from a closed to an open
Qa-SNARE motif capable of binding Nyv1 and allowing further SNARE complex assembly.
Vps33 is then thought to act as a molecular chaperone by managing the interaction between RSNAREs, located on the apposed bilayer, and the open (primed) conformation of Qa-SNAREs
though the precise mechanisms of these interactions are somewhat unclear (Baker et al, 2015;
Baker & Hughson, 2016). Importantly, both R- and Qa-SNARE motifs can simultaneously bind
Vps33 and orient themselves in the same direction (N-to-C). Both SNAREs also align with each
other in the same register when bound to Vps33, with their central zero-layer residues proximal
to one another. Lastly, removal of the Vps33 region that interacts with the N-terminals of both
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Nyv1 and Vam3 disrupted binding between the SM protein and SNAREs, though this mutant
could still stably fold, bind Vps16, and incorporate into the HOPS complex (Baker et al, 2015;
Zick & Wickner, 2016). These data strongly support the function of Vps33 acting as an SM-like
protein by chaperoning the interactions between R- and Qa-SNAREs during trans-SNARE
complex assembly.

Endosome Derived Golgi Fusion
While synaptic and vacuolar fusion have been well characterized, the mechanisms of
endosome-to-Golgi fusion are far less understood. In yeast, Vps45 and Sly1, are the two known
SM-like proteins primarily functioning at the Golgi. Both Vps45 and Sly1 share similar
regulatory functions when compared to Munc18-1 and Vps33, mainly in chaperoning the
open/closed conformations of syntaxin-like Qa-SNAREs Habc domains. Unlike the previously
described SM-SNARE interactions, Vps45 and Sly1 do not participate in further steps of transSNARE complex pairing or alignment. In fact, both Vps45 and Sly1 share similar binding
mechanisms interacting with the N-terminal regions (N-peptide) of Golgi Qa-SNAREs Tlg2 and
Sed5, respectively, proceeding the Habc domain (Burkhardt et al, 2008; Furgason et al, 2009;
Demircioglu et al, 2014). Furthermore, nuclear magnetic resonance (NMR) studies did not reveal
a closed conformation adopted by Tlg2p, although a key N-terminal portion of the SNARE motif
was missing from the bacterial purified construct used in this analysis. This arguably could affect
the SNARE motif interactions present in the closed auto-inhibitory conformations seen in other
Qa-SNAREs of the syntaxin family (Dulubova et al, 2002; Furgason et al, 2009; MacDonald et
al, 2010).
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High resolution structural analysis will be necessary to further assess the exact
mechanisms by which Vps45 chaperones the closed conformation of Tlg2. Additionally, while
many in vivo and in vitro assays support the SM-like function of Vps45 in fusion, there are
currently no lipid or content mixing assays to test this assertion.

Understanding the Limitations of Fusion Assays
Interpreting the various and sometimes conflicting results of different fusion assays relies
on understanding the strengths and limitations of the specific assays employed as well as the
quality and specificity of data that can be gleaned from them (Chen et al, 2006). Reconstituted
membrane fusion depends on the physical state of the membranes, proper SNARE incorporation
and pairing, and accessory protein factors such as tethers, Rab’s, and SM’s to achieve efficient
fusion at near physiological concentrations of proteins (Zucchi & Zick 2011; Wickner & Rizo,
2017). As previously mentioned, early liposome fusion assays conducted with SNARE’s alone
required excessive amounts of SNARE proteins loaded on the membrane surface to achieve
significant rates of fusion (Weber et al, 1998; Paumet et al, 2001). These early fusion assays
were primarily quantified using lipid mixing strategies and did not incorporate a measure of full
fusion as in the protected luminal content mixing assays. Lipid mixing assays are generally
measured using fluorescently tagged lipids and mixing is monitored by observing the increase in
fluorescence of a quenched lipid (NBD-PE), as membrane mixing will dilute the fluorophores
and allow dequenching from the quenching lipid (Liss Rhod-PE) (Weber et al, 1998). One major
limitation to interpreting the lipid mixing assay is that fluorescent dequenching can arise from
membrane lysis and reannealing, hemifusion where only outer leaflets mix, as well as full fusion
and protected content mixing. Content mixing assays were first developed using small molecules
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such as 1-aminonaphthalene-3,6,8-trisulfonate (ANTS), a polyanionic fluorophore, and alpha'dipyridinium p-xylene dibromide (DPX), a cationic quencher, loaded into separate t and vSNARE liposome populations (Smolarsky et al, 1977). Content mixing is then monitored by
measuring the quenching of ANTS fluorescence by DPX upon fusion pore opening and the
luminal mixing of the two previously separated molecules. Methods for content mixing now
commonly utilize fluorescently conjugated protein with high affinities, such as streptavidin and
biotin, and content mixing is measured via the increased buildup of FRET between the
fluorescent tags (Cy5 and PhycoE, respectively). More recently, reconstituted fusion assays
have been developed that can measure both lipid and content mixing simultaneously (Zucchi &
Zick 2011; Liu et al, 2017). The obvious advantage of this assay is the ability to relate lipid
mixing data to full fusion and content mixing information simultaneously using the same
liposome populations. The simultaneous assay also has the added benefit of being able to
quantify what percent of monitored fusion may occur from lysis or leakiness of the membranes
and not true fusion mechanisms. In these assays, free/external unlabeled streptavidin is added in
excess to control wells so that any biotin-PhycoE released from the liposomes due to lysis or
leakiness immediately binds to unlabeled streptavidin preventing a FRET signal. The numerous
advantages of the simultaneous assay have made it a strong model for analyzing the multiple
stages of the fusion reaction and interpreting those results with a higher level of confidence than
the data gained from lipid mixing alone. While the simultaneous assay is gaining considerable
traction in its implementation; lipid mixing assays are still considered the standard and are
frequently used primarily because they are cheaper, far easier to implement, and data collection
and analysis is more straight forward.
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The method of liposome formation, as well as SNARE density, can also negatively or
positively effect fusion. Among the many liposome formation procedures, the standard method
involving comicellization of lipids and proteins and the direct method of incorporating detergentsolubilized proteins into the preformed liposomes are widely used for SNARE reconstitutions
into proteoliposomes. While the direct method produces more homogenously sized liposome
populations, their propensity to fuse is considerably less than liposomes prepared by the standard
comicellization method (Chen et al, 2006).
The higher propensity for liposomes to fuse when generated by the standard method may
be due to the inconsistent size distributions of these liposome populations. Liposomes produced
by the direct method are of very uniform sizes (~100nm), whereas liposome populations
produced by comicellization exhibited more variable sizes (~50-125nm). Furthermore, liposomes
with high SNARE densities produce vesicles considerably smaller in size than the average
secretory vesicles and are prone to create particles of very small sizes (<10nm) that are more
likely to be micelles than vesicles. It is hypothesized that the small size of these liposomes
produces high geometric curvature resulting in substantial curvature stress on the membrane.
Theoretically, this negative curvature stress will cause the liposomes to be more prone to stalk
formation and fusion as to relieve the stress on the membrane (Chen et al, 2006). This, in
addition to the excessive SNARE densities that may be present on such small vesicles or
micelles, may be the reason for the increased lipid mixing found in fusion assays produced by
the standard method of comicellization.
The method of dialysis is also believed to be of considerable importance in preserving the
integrity of the membrane of reconstituted proteoliposomes. Some early fusion assays used large
4L buffer tanks to dialyze many samples simultaneously overnight without buffer or adsorbent
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bead exchanges (Weber et al, 1998; Paumet et al, 2004). Newer simultaneous methods have
stressed the importance of changing buffers, temperatures, and buffer volumes during the
dialysis procedure for proper liposome formation and increased membrane integrity (Liu et al,
2017).

The Dynamin-Related Protein, Vps1, and Membrane Fusion
While Vps1 has traditionally been characterized as a membrane fission protein, its role in
fusion has only been minimally explored (Peters et al, 2004; Alpadi et al, 2013; Kulkarni et al,
2014). Recent structural studies of Vps1 have shown that it primarily localizes and functions at
endosomal compartments and self assembles into long helical structure in the presence slowly
hydrolysable GTP analogue, guanylyl-(alpha, beta)-methylene-diphosphonate (GMPCPP)
(Varlakhanova et al, 2018). Studies from our lab have found that Vps1 interacts with Vps51, a
subunit of the GARP tethering complex, through two residues that are conserved in the human
Vps51 homolog (Ang2) and mutation of these residues resulted in retrograde trafficking defects
of endosomal SNARE Snc2 (Saimani et al, 2017). Further studies from our lab have shown that
Vps1 interacts with Snc2 and Vti1 in Yeast-2-Hybrid (Makaraci et al, 2018) though theses
interaction could not be validated using GST-pulldowns with the purified SNARE proteins and
Vps1p (unpublished data). Vps1 has also been proposed to play a role in vacuolar membrane
fusion by sequestering an available pool of Qa-SNARE Vam3 and facilitating it’s interaction
with the HOPS complex (Alpadi et al, 2013). Further research from the same lab later suggested
a mechanism by which Vps1 facilitates the transition from hemifusion to content mixing through
the oligomerization of Vps1 and its binding to the SNARE domain of Vam3 to increase the
number of available Qa-SNAREs for fusion. While these assays assert a role for Vps1 in
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vacuolar membrane fusion, no other research has validated these findings and Vps1’s
involvement in endosomal fusion has not been investigated using reconstituted fusion assays.
For these reasons, my thesis project involved the development of both lipid mixing and
simultaneous lipid and content mixing assays using reconstituted proteoliposomes to measure the
competency of SNARE-mediated endosome-to-Golgi retrograde fusion in yeast. The assays
include proteoliposomes harboring yeast endo-to-TGN SNARE proteins (Snc2p, Tlg2, Tlg1,
Vti1) and the dynamin-related protein Vps1. These in vitro reconstitution assays will be used to
characterize the mechanism by which Tlg2 is activated for full fusion and content mixing as well
as the role of Vps1 in the fusion reaction. My findings presented here could eventually help
elucidate the specific mechanisms by which SM’s and other accessory proteins regulate SNAREdependent endosome-to-Golgi fusion.
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MATERIALS AND METHODS

For my study, yeast endosome-to-trans Golgi Network (TGN) SNARE proteins were
reconstituted into fluorescently labeled liposomes to assess their fusion efficiency in the presence
of Vps1 and nucleotide. Briefly, purified yeast SNARE proteins were isolated from E. coli using
recombinant protein technology and inserted into liposomes by detergent-based methods. Lipid
mixing was quantified by measuring the fluorescent dequenching of NBD labeled lipids from
rhodamine-labeled as described in Weber et al, 1998 and Paumet et al, 2001. Later simultaneous
fusion assays incorporated a measure of content mixing and/or leakiness that was monitored by
the increased FRET signal of Cy5-streptavidin and PhycoE-biotin as in Zucchi and Zick, 2011
and Liu et al, 2017.
All genes for the yeast recombinant proteins being studied (Vps1p, Tlg1p, and Snc2p)
were first inserted into plasmids containing Histidine (His) or Glutathione-S-Transferase (GST)
tags and the recombinant vectors were transformed into E. coli. Competent E. coli cells were
used to express the recombinant proteins of interest, and affinity chromatography was used to
purify and isolate individual SNAREs and accessory proteins. The purified SNAREs were
reconstituted into proteoliposomes containing fluorescently labeled lipids, nitrobenzoxadiazole
(NBD) and lissamine rhodamine B (Liss Rhod), using a detergent-based reconstitution strategy.
After reconstitution, fusion efficiency was assessed by measuring the dequenching of
NBD fluorescence in the presence of the additional protein being studied (Vps1) and nucleotide
over two hours. Simultaneous assays were conducted by measuring dequenching of NBD
florescence and the buildup of FRET between Cy5-streptavidin and PhycoE-biotin in the
presence of Vps1 and nucleotide for three hours.
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Small Scale Protein Expression
All plasmid constructs were first tested under small-scale conditions to optimize the best
parameters for protein expression in subsequent large-scale purifications. The method to test all
constructs followed these same general parameters, except for kanamycin and chloramphenicol,
which were used as selective antibiotics for plasmids introduced into Rosetta (DE3) pLysS (his63C-Tlg1p, his6-3C-Vti1p, and his6-3C-Snc2p). After introduction of pET6xHN vector harboring
the DNA sequence for Vps1 into SoluBl21 (DE3) competent E. coli strains, positive colonies
were confirmed by restriction digest and inoculated into 3 mL starter cultures of terrific broth
(TB) with a working concentration of 100 µg/mL carbenicillin at 37 ◦C overnight with shaking
(250 rpm). The overnight samples were diluted in a 1:20 ratio with a fresh 5 mL culture of
terrific broth and carbenicillin the following morning and allowed to grow to an OD of ~0.6
measured at 600nm. The 5 mL cultures were then split into 2 mL uninduced (UI) samples and
3mL induced (I) samples. The induced samples were inoculated with 1 mM Isopropyl β-D-1thiogalactopyranoside (IPTG) and both UI and I samples were incubated on ice for 15 minutes
with vigorous shaking every few minutes. After the ice incubation, both UI and I samples were
tested for protein expression at standardized temperatures of 24 ◦C, 30 ◦C, 37 ◦C, and sometimes
16 ◦C when necessary (for 10hr, 7hr, 4hr, and 20hr respectively) shaking at 280 rpms. The UI
and I samples were then pelleted by centrifugation in a table top centrifuge (Beckman J2-HS) for
20 minutes at 4 ◦C and 3000xg. The supernatant was removed by decanting, and the pellet was
resuspended and lysed by pipetting with 500 µL 1xPBS (Phosphate Buffered Saline, pH 7.4) and
100 µL 2x or 5xSDS (Sodium Dodecyl Sulfate) lysis buffer. The sample was then sonicated
using a Branson 250 sonifier fitted with a titanium ultra-high tapered microtip for ~45sec-1min
with output controls set to 2-3 and one second bursts. The sonicated samples were heated to
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95 ◦C for 5 minutes using a hot plate and clarified by centrifugation at max speed (13,000xg) for
15 minutes two times. After centrifugation, 15 µL of the supernatant was carefully harvested
from the very top of the centrifuge tubes and applied to an SDS-PAGE gel for visualization. The
SDS-PAGE gel was loaded with UI and I samples side by side of the same protein variants and
temperatures to compare the best expression conditions for large-scale purifications. All SDSPAGE gels were stained with Coomassie blue for 7 minutes and destained for one-hour rocking
at room temperature. Then, the destain buffer was changed and the gel was left rocking overnight
for analysis the next morning.

His-tagged Protein Expression and Purification
The his6-3C-Tlg1p, his6-3C-Vti1p, and his6-3C-Snc2p constructs were kind gifts from Dr.
Joji Mima (Osaka University). These three constructs were introduced into Rosetta (DE3)pLysS
E. coli chemically competent cells (Novagen) containing the additional pLysS plasmid for
expression of rare eukaryotic codons. All the transformed strains and conditions for protein
expressions were first developed in small-scale trials before subsequent large-scale purification
procedures. The transformed cells were inoculated into 3 mL starter cultures of terrific broth
containing 34 mg/mL chloramphenicol and 50 mg/mL kanamycin for the three SNARE
constructs. The starter cultures were left to grow overnight at 37 ◦C in a shaking incubator at 220
rpm. The 3 mL starter cultures were then used to inoculate 500 mL sample cultures of TB
containing the same working concentrations of antibiotics as previously mentioned. The sample
cultures were allowed to grow in a shaking incubator at 37 ◦C (280 rpm) to an optical density of
0.6 (at 600 nm). Once the samples reached an OD of 0.6, the 500 mL culture was induced with
IPTG at a 1 mM working concentration. For his6-3C-Tlg1p and his6-3C-Vti1p, the induced
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samples were grown at 37 ◦C for 3.5 hours, while his6-3C-Snc2p was induced at 16 ◦C for 20
hours, and 6xHN-Vps1 at 30 ◦C for 6 hours. The induced cultures were collected and evenly
decanted into two pre-weighed 275 mL Sorvall centrifuge bottles. The Sorvall bottles were then
centrifuged at 4000xg in a Beckman J2-HS centrifuge outfitted with a JA-14 rotor for 20 minutes
at 4 ◦C. After spinning, the supernatant was decanted off and the bottle was reweighed to
calculate the left-over pellet weight (generally ~1.5 g). The pellets were then snap frozen by
submerging the bottles in liquid nitrogen and immediately stored at -80 ◦C until the time of
purification.
To purify the recombinant proteins from E. coli, the pelleted cells were chemically lysed
by pipette using 2 mL of xTractor buffer (Clontech) per 100 mg of cell pellet, 5 µL DNase I
(50U/µl, Thermo Scientific) per 1 g cell pellet, and 200 µL per 1-gram cell pellet of Lysozyme
(10 mg/mL, Acros). The lysis mixture was pipetted until the pellet was thoroughly disrupted and
protease inhibitors were added at the following working concentrations; 0.2 mM PMSF, 3.2 µM
Bestatin, 1 µM Pepstatin A, 2 µM Leupeptin, 1.54 µM Aprotinin. Due to its short half-life,
additional PMSF was added after clarification of the sample by centrifugation, during incubation
with His60 Ni resin (Clontech), and to the dialysis buffer during overnight dialysis. The lysed
sample was then transfer to a clean 50 mL polycarbonate centrifuge tube (Beckman Coulter) and
completely submerged in a 200 mL glass beaker packed with ice for sonication. The 50 mL tube
was sonicated on ice using a Branson 250 sonifier fitted with a titanium ultra-high tapered
microtip for 1 minute 30 seconds with output controls set to 3 amps and intermittent 1 second
bursts. The sonicated samples were then centrifuged in the same 50 mL tubes using a Beckman
JA-20 rotor at 15,000xg for approximately 30 minutes or until the supernatant was completely
clarified and free of cellular debris. The clarified supernatant was then decanted through a cheese
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cloth (making sure not to disrupt the pelleted cellular material) into 50 mL falcon tubes for
incubation with His60 Ni resin. The clarified supernatant containing the expressed recombinant
proteins was incubated by rocking at 4 ◦C for 2 hours with 1-2 mL of His60 Ni resin in 50 mL
Falcon tubes.
After incubation the protein lysate and resin mixtures were transferred to 10 mL
disposable gravity columns (Bio-Rad) and the lysate was passed through the column to pack the
resin. The resin was first equilibrated using 10 mL of equilibration buffer (Clontech) per 1 mL of
resin making sure to never allow the column to run dry. After equilibration, 10 mL of binding
buffer (Clontech; made by mixing 7.1 parts equilibration buffer with 0.9 parts elution buffer) per
1 mL of resin was added to the column and allowed to pass through the column, followed by 10
mL of elution buffer (Clontech) per 1 mL of resin. All flow through samples were collected and
saved for validation using SDS-PAGE and visualized with Coomassie blue staining. Eluted
samples were pooled based on concentration and purity prior to dialysis against 50 mM Trisbuffer containing 10% glycerol. Dialyzed protein samples were concentrated based on the
desired concentrations using 6 mL Pierce concentrators (Thermo Scientific) that were at least
half the molecular size of the purified protein (10 kDa, 30 kDa, and 70 kDa). Protein
concentrations were quantified using a Qubit protein assay kit (Invitrogen) and samples were
snap frozen in liquid nitrogen and stored at -80 °C in 20% glycerol for long-term storage.

GST-tagged Protein Expression and Purification
The GST-Tlg2 plasmid was constructed and introduced into SoluBL21 E. coli competent
strains by fellow graduate student Ehsan Suez. After small scale trails to test for expression
conditions, the transformed cells were inoculated into a 3 mL starter culture of TB media
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containing 100 µg/mL of carbenicillin and allowed to grow overnight in a shaking incubator at
37 ◦C (230 rpm). The starter culture was used to inoculate a fresh 500 mL culture of TB media
contain 100 mg/mL of carbenicillin and incubated at 37 ◦C shaking at 280 rpm until the culture
reached an OD of 0.6 (600nm). While on ice, 1mM of IPTG was added to the 500 mL culture
and it was vigorously shaken every few minutes for a 15-minute ice incubation. The 500 mL
culture was then placed in a shaking incubator (280 rpm) and grown at 30 ◦C for 6 hours to
express the GST-Tlg2 recombinant protein. After induction, the sample was transferred into two
pre-weighed 275 mL Sorvall centrifuge bottles and centrifuged at 4000xg in a JA-14 rotor for 20
minutes at 4 ◦C. The pelleted samples were reweighed, snap frozen, and stored at -80 ◦C as
described in the previous section.
The pelleted samples were lysed by pipetting and vortexing on ice with 50 µL of 1xPBS
per 1 mL of starting sample culture containing 1 mM Dithiothreitol (DTT). Once the pellet was
thoroughly resuspended, 150U per 1 gram of pellet of DNase1 (50U/µL) was added along with
200 µL per 1 gram of pellet of Lysozyme (10 mg/mL) and the sample was incubated on ice for 1
or 2 minutes with intermittent vortexing. Protease inhibitors (PMSF, Bestatin, Pepstatin A,
Leupeptin, Aprotinin) were added to the lysed samples in the exact same concentration and at the
same times as mentioned in the previous section. The lysed sample was transferred to 50 mL
polycarbonate centrifuge tubes and submerged in a 200 mL beaker filled with ice for sonication.
Sonication was performed using a Branson sonifier 250 exactly as previously described. The
sonicated sample was clarified by centrifugation at 15,000xg and 4 ◦C for approximately 30
minutes in a Beckman JA-20 rotor or until the sample was completely free of cellular debris. The
clarified sample was then decanted through cheese cloth, taking care not to disturb the pellet, and
filtered with a 0.45 µm sterile filter (FisherBrand) into a 50 mL Falcon tube.
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The recombinant GST-Tlg2 protein was purified using a GSTrap HP column (GE
healthcare) prepacked with 5 mL of Glutathione Sepharose High Performance resin. For low
pressure liquid chromatography, a peristaltic pump with adjustable rotation speeds was used with
size 14 rotor head and tubing (Masterflex). All flow rates were precalibrated on the pump using
1xPBS buffer and the GSTrap column before protein was loaded into the column. The column
was first equilibrated with 8 bed volumes of binding buffer (10mM PBS pH 7.4) using a 10
mL/min flow rate making sure to never allow the column to go dry. The clarified lysate was then
passed through the column for incubation with the resin by lowering the flow rate to 0.2 mL/min.
After incubation, the column was washed with another 8 column volumes of binding buffer
(10mM PBS pH 7.4) using a 5 min/mL flow rate. The column was eluted with 8-15 mL of 50
mM Tris buffer (pH 8) containing 15 mM of freshly added glutathione and lowering the flow
rate to 1-2 mL/min. The eluted sample was captured in 1 mL fractions and analyzed using SDSPAGE and Coomassie blue staining as previously mentioned. The 1 mL fractions were pooled
based on protein concentration and purity and were dialyzed and saved in the same fashion as
described early.

Lipid Mixing Proteoliposome Reconstitutions
All lipids for proteoliposome reconstitutions were purchased from Avanti Polar
Alabaster, Alabama. The proteins used for reconstitutions were expressed and purified as
previously described. Glass Gastight syringes (Hamilton) with PTFE Luer Locks were used for
handling all lipids solubilized in chloroform as it will degrade plastics and leave impurities in the
lipid solutions. The syringes were cleaned with 10 passes of acetone followed by 10 passes of
chloroform before and after each use. Donor fluorescent liposomes bearing the v-SNARE his6-
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3C-Snc2p were prepared by premixing 6 mM lipid stocks in chloroform to make a 200 µL
solution in clean 16 x 125 mm glass test tubes prerinsed with chloroform. All the lipids used for
the fusion assay were 18:1 dioleoyl variants: DOPC (1,2-dioleoyl-sn-glycero-3-phosphocholine),
DOPS (1,2-dioleoyl-sn-glycero-3-phospho-L-serine, sodium salt), NBD-PE (1,2-dioleoyl-snglycero-3-phosphoethanolamine-N-7-nitro-2-1,3-benzoxadiazol-4-yl), and Liss Rhod-PE (1,2dioleoyl-sn-glycero-3-phosphoethanolamine -N-lissamine rhodamine B sulfonyl) prepared in a
82:15:1.5:1.5 molar ratio, respectively (Table 2). The mixed lipid solutions were then dried into a
lipid film under a gentle stream of nitrogen for 3-5 minutes and vacuum desiccated using a BelArt plastic vacuum desiccator, 230 mm plate size (Cole-Parmer) for a minimum of one hour to
remove any remaining trace amount of chloroform.
For reconstitution of v-SNARE containing proteoliposomes, the dried lipid film was
dissolved in a 400 µL solution of reconstitution buffer (25 mM HEPES-KOH [7.4 pH], 400 mM
KCl, 1 mM DTT, 10% glycerol) containing 40 nM for initial trials or, 6 µM of his6-3C-Snc2p for
later assay, and 1% octyl β-D-glucopyranoside (βOG), a nonionic detergent commonly used to
solubilize membrane proteins and lipids (Table 3). After addition of the protein/βOG-solution
the lipids were dissolved by gentle agitation flicking the test tube every couple of minutes at
room temperature until the lipid film was no longer visible and the solution appeared
homogenous. For vesicle formation, the homogeneous solution was then vortexed vigorously at
room temperature while 800 µL of reconstitution buffer was added drop-wise to the 400 µL
protein/lipid solution to rapidly dilute the βOG detergent below its critical micellar concentration
(CMC). The excess detergent was removed by extensive dialysis (Fisherbrand 6,000-8,000
nominal MWCO dialysis tubing) against 4 L of reconstitution buffer with 4 g of SM-2 Adsorbent
Bio-beads (Bio-Rad) for 2 hours at room temperature then incubated overnight at 4 ◦C. All
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separate reconstitutions were done simultaneously and dialyzed together with samples distributed
evenly and the total volume of dialysate did not exceed 6 mL per 4 L of buffer.
The vesicles were recovered from the dialysis tubing by pipette and samples were
remeasured to account for volume changes during dialysis. The ~1.2 mL dialysate was gently
and thoroughly mixed with an equivalent volume of 80% Nycodenz solution dissolved with
reconstitution buffer in an 11 x 60 mm polypropylene ultracentrifuge tube (Beckman Coulter).
The resulting 40% Nycodenz solution was then overlaid with 700 µl of 30% Nycodenz using a
syringe by gently swirling the syringe tip above the 40% layer and very delicately overlaying the
30% Nycodenz over the top. A final 250 µL Nycodenz and glycerol free layer (i.e.,
reconstitution buffer) was applied over the 30% layer in the same fashion. Upon proper layering
one should be able to see the three visibly separated layers before advancing to centrifugation.
The ultracentrifuge tubes were then transferred to a TH-660 swing bucket rotor and centrifuged
at 4 ◦C for 4 hours at 48,000 rpm in a Sorvall WX+ Ultracentrifuge (Thermo Scientific). After
ultracentrifugation, vesicles were harvested from the 0/30% Nycodenz interface in 100-200 µL
fractions and saved in 1.5 mL screw cap centrifuge tubes on ice in a 4 ◦C refrigerator. Samples
were generally measured the next day but can be stored for ~3 days without significant loss of
fusion efficiency.
The non-fluorescent acceptor liposomes bearing pre incubated t-SNARE bundles were
prepared in essentially the same method as described above except the 200 µL lipid/chloroform
solution was prepared with 15 mM DOPC and DOPS lipids premixed in an 85:15 molar ratio,
respectively (Table 2). The mixed lipids were prepared in a glass test tube, dried under a gentle
stream of nitrogen, and vacuum desiccated as previously mentioned for donor liposomes. To
form t-SNARE bundles, the necessary SNAREs (his6-3C-Tlg1p, his6-3C-Vti1p, and GST-Tlg2)
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were incubated for 16 hours at 4 ◦C in 1 mL of reconstitution buffer containing 40 nM
concentrations for individual SNARE protein during initial trails and 2 µM concentrations for
later fusion assays (Table 3). After SNARE incubation, 1% βOG (w/v) was added to the 1 mL
reconstitution buffer containing the t-SNARE bundles and the assembled SNAREs were
incubated for 25 minutes at 4 ◦C. The solution containing βOG detergent was then used to gently
dissolve the lipid film as before. For vesicle formation, the homogenized solution was vortexed
vigorously at room temperature while 2 mL of reconstitution buffer was added dropwise to the 1
mL protein/lipid solution to rapidly dilute the βOG detergent below its critical micellar
concentration. The vesicles were then dialyzed extensively against reconstitution buffer and SM2 Bio-beads to remove any traces of βOG detergent as previously described. After dialysis, the
vesicles were collected and measured volumetrically to account for changes during dialysis. The
~3 mL of dialysate was then evenly split into two ~1.5 mL fractions in 11 x 60 mm
polypropylene ultracentrifuge tubes and each was thoroughly mixed with an equivalent volume
(~1.5 mL) of 80% Nycodenz to create a 40% Nycodenz layer. The bottom 40% layer of the
gradient was overlaid with 750 µL of 30% Nycodenz, then a final 0% layer of reconstitution
buffer lacking glycerol and Nycodenz was added to the very top as previously described. The
layers should be visibly separated before moving to floatation by ultracentrifugation. Acceptor
proteoliposomes containing t-SNAREs were centrifuged with a TH-660 swing bucket rotor at 4
◦C

for 3 hours 40 minutes at 55,000 rpm in a Sorvall WX+ Ultracentrifuge and the vesicles were

harvested from the 0/30% interface in 200 µL fractions.
To create control liposomes containing no SNARE proteins, the above methods were
followed except no SNARE proteins were added to the reconstitution buffer solutions containing
the 1% βOG detergent.
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Lipid Mixing Fusion Assay
Lipid mixing assays were conducted in black Costar 96-well FlouroNunc plates (Thermo
Scientific) unless otherwise mentioned in the figure descriptions. Into each well, 5 µL of vSNARE containing donor vesicles was mixed with 45 µL of t-SNARE containing acceptor
vesicles by gentle pipetting. The 96-well plates containing the mixed liposomes were then
preincubated at 4 ◦C protected from light for 2 hours with gentle agitation. After incubation, 2.5
mM MgCl2 was first added to both control and experimental samples, followed by 100 µM of all
GTP variants (GDP, GTP, and GTgP) into the designated wells (Table 4). 6xHN-Vps1 was
added last at a concentration of 1 µM, which was determined by using varying concentrations of
Vps1 in previous pilot experiments. The samples were then incubated at 37 ◦C with gentle
agitation for 8 minutes and placed in the fluorescent plate reader for 5 minutes at 37 ◦C to
acclimate before readings were taken. Lipid mixing was measured by the dequenching of NBDPE lipids from Liss Rhod-PE and NBD fluorescence was measured at 460 nm excitation and 538
nm emission with a 515 nm cutoff filter. Increasing NBD fluorescence was monitored by kinetic
readings every 2 minutes for a total of 2 hours at 37 ◦C with shaking every 5 seconds before
readings. After 2 hours, the plate was removed from the reader and 10 µL of 2.5% Triton X-100
and all samples were simultaneously mixed using a multichannel pipette. Endpoint readings were
taken immediately and 10 minutes after Triton X-100 addition to solubilize the liposomes and
determine the maximum lipid mixing signal. The resulting data were normalized, and fusion was
quantified as the change in NBD signal within the initial and endpoint readings after Triton X100 addition.
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Simultaneous Lipid and Content Mixing Proteoliposome Reconstitutions
All lipids used for the simultaneous fusion assay were purchased from Avanti Polar
Alabaster, Alabama. Before use, all lipid stock solutions were removed from the -20 ◦C freezer
and allowed to equilibrate to room temperate in the dark. The proteins used for reconstitutions
were expressed and purified as previously mentioned. Lipids were transferred from stock
solution and mixed using a microdispenser with positive replacement glass capillaries
(Drummond) in 16 x 125 mm glass test tubes that were prerinsed three times with chloroform.
All tubes were wrapped in aluminum foil and kept out of light to avoid photobleaching and
photo-oxidation of the lipids whenever possible. While both content mixing and lipid mixing
vesicles were prepared simultaneously with equivalent lipid and protein concentrations, the two
assays were reconstituted into separate vesicle populations and measured in parallel wells due to
fluorescent interference of NBD with PhycoE/Cy5 FRET.
To create v-liposome populations for the lipid mixing assay 5 mM of total lipids (DOPC,
DOPS, DOPE [1,2-dioleoyl-sn-glycero-3-phosphoethanolamine], Ergosterol, NBD-PE, and Liss
Rhod-PE) were mixed in a clean glass tube at 39:19:19:20:1.5:1.5 molar % ratios, respectively
(Table 5). To create v-liposomes populations for the content mixing assay the exact same
concentrations were used except fluorescent lipids (NBD-PE and Liss Rhod-PE) were omitted
and the extra three molar percent was added evenly to DOPC, DOPS, and DOPE as seen in
Table 5. For both preparations, the mixed lipid solutions were dried under a gentle stream of
nitrogen while swirling the test tube to create a lipid film at the bottom of the tube. The tubes
were then wrapped in aluminum foil with a hole poked in the top and vacuum desiccated
overnight to remove any trace chloroform. After overnight drying, both lipid films were hydrated
with 420 µL of reconstitution buffer containing 2% βOG and vortexed vigorously for about 2
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minutes to completely suspend the lipid film. The dissolved lipids were then incubated at room
temperature for 15 minutes then sonicated twice in a bath sonicator for 5 minutes each time. At
this step, the mixed lipids solutions can be snap frozen in liquid nitrogen and stored at -80 ◦C for
up to one month. Reconstitutions of v-SNARE proteoliposomes for lipid mixing were prepared
by adding 5 µM his6-3C-Snc2p (29.45 µL) into 100 µL of reconstitution buffer containing 1 %
βOG and mixing the protein solution with 200 µL of the fluorescent premixed lipid solution and
an additional 170.55 µL of reconstitution buffer containing 1% βOG detergent (Table 6). The
mixed lipid/protein solution was then incubated at room temperature for 25 minutes with end
over end rotation. To prepare v-liposomes for content mixing, the reconstitution was carried out
using the same method except 200 µL of the premixed lipid solution lacking florescent PE lipids
was used and the 200 µL of reconstitution buffer containing 1% βOG was replaced with 200 µL
of a 16 µM Cy5-Steptavidin (THERMO) solution containing 1% βOG (Table 6).
To prepare t-liposome populations for both the lipid and content mixing assays, 5 mM of
total lipids (DOPC, DOPS, DOPE, Ergosterol) were premixed in a clean glass test tube in a
38:20:20:20 molar % ratio, respectively (Table 5). The lipids were dried into a lipid film and left
to vacuum desiccate overnight to remove any trace chloroform, exactly as before. After drying,
the lipid film was hydrated with 420 µL of reconstitution buffer containing 1% βOG while
vortexing vigorously for about 2 minutes until the lipids were completely suspended. Both
content and lipid mixing used the same 420 µL mixed lipid solution during the fusion assay. To
prepare t-SNARE bundles, 1 µM working concentrations of each SNARE protein (his6-3CTlg1p, his6-3C-Vti1p, and GST-Tlg2) were mixed in a centrifuge tube and incubated for 16
hours with end over end rotation at 4 ◦C (Table 7). Before reconstitution, 1% βOG (w/v) was
added to the assembled t-SNAREs and they were again incubated at 4 ◦C for 25 minutes. Lipid
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mixing liposomes were reconstituted by mixing the t-SNARE bundles with 200 µL of the 5 mM
premixed lipid solution containing 2% βOG and 120 µL of reconstitution buffer with 1% βOG
(Table 8). The protein/lipid solution containing βOG was wrapped in aluminum foil and
incubated at room temperature for 25 minutes using slow rotation. The reconstitution of tliposomes for the content mixing assay was prepared using a similar method except that the 120
µL of reconstitution buffer containing 1% βOG was exchanged for 120 µL of a 16.7 µM solution
of PhycoE-Biotin (Invitrogen) also containing 1% βOG (Table 8).
After incubations all samples were transferred to prewetted 6,000-8,000 MWCO dialysis
tubing for subsequent dialysis. The ~500 µL liposome samples were then excessively dialyzed
for complete detergent removal against reconstitution buffer containing SM-2 beads. The
samples were first dialyzed at room temperature for one hour in 500 mL of reconstitution buffer
containing 1 g of SM-2 Bio-beads. After an hour, the 500 mL of dialysis buffer was exchanged
with fresh reconstitution buffer containing another 1 g of SM-2 beads and dialyzed at 4 ◦C for
two hours. A final overnight dialysis was prepared by transferring the dialysis bags to fresh
buffer tanks containing 1 L of reconstitution buffer and 2 g of SM-2 Bio-beads (Table 9). All
buffer tanks were wrapped in aluminum foil to prevent photobleaching of fluorescent lipids and
photo-oxidation. After dialysis, the ~500 µL dialysate samples were collected by pipette and
transferred to 2 mL centrifuge tubes on ice for floatation gradient purification.
For proteoliposome purifications, the dialysate was volumetrically measured to account
for volume changes during dialysis and ~450 µL of sample was collected for purification. The
~450 µL samples were then mixed with reconstitution buffer to make a total of 900 µL.
Nycodenz stock solution were made for the floatation gradients in the following concentrations;
70% Nycodenz was dissolved in reconstitution buffer contain 2% glycerol, 25% Nycodenz was
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prepared by diluting the previously made 70% Nycodenz in reconstitution buffer containing 10%
glycerol. The 900 µL samples were thoroughly mixed by pipetting with an equivalent volume of
70% Nycodenz (making a 35% Nycodenz layer) and then transferred slowly into 11x60 mm
polypropylene ultracentrifuge tubes. The 25% Nycodenz solution was then overlaid on top of the
35% layer using a syringe and slowly adding 1.6 mL of 25% Nycodenz carefully above the
bottom layer. Lastly, 500 µL of a 0% Nycodenz layer containing 10 % glycerol was carefully
overlaid above the 25% layer in the exact same fashion. After adding the Nycodenz gradients
each individual layer was clearly visible prior to ultracentrifugation. The ultracentrifuge tubes
were loaded into swing buckets for a TH-660 rotor and centrifuged at 55,000 rpm for 2 hours at
4 ◦C in a Sorvall WX+ ultracentrifuge. The liposome samples layers should be clearly visible
after ultracentrifugation (Figure 1). The purified proteoliposomes were carefully harvested from
the top interface in 500 µL fractions using a syringe and saved on ice in 1.5 mL screw cap
centrifuge tubes wrapped in aluminum foil. The proteoliposome samples can be saved at 4 ◦C for
24 hours with no apparent loss of activity, or snap frozen and saved in liquid nitrogen or -80 ◦C
with only ~10 % loss of activity (Liu et al., 2017).

Simultaneous Fusion Assay
Lipid and content mixing assays were conducted simultaneously in parallel in black
Costar 96-well FlouroNunc plates. For both assays, 5 µL of v-liposome was gently mixed by
pipette with 45 µL of t-liposomes and allowed to incubate at 4 ◦C with gentle agitation covered in
the dark for two hours. Blank control samples were prepared by mixing 5 µL of v-liposomes with
65 µL of reconstitution buffer to account for the final well volume of tested samples. After
preincubation, 2.5 mM MgCl2 was added to all loaded wells followed by 100 µM of the various
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GTP variants (GDP, GTP, and GTgP) to their selective wells (Table 4). Reconstitution buffer
was used to balance the volumes between wells, so all samples had the same final volume in
each well. Vps1 was added last to all test wells in 1 µM final concentration and all samples were
gently mixed in unison by pipetting with a multi-channel pipette. The 96-well plate was
incubated at 37 ◦C with gently agitation covered from light for 8 minutes then placed in a
SpectraMax M5 fluorescent plate reader for 5 minutes at 37 ◦C to acclimate before readings were
taken. Kinetic readings were taken every two minutes at 37 ◦C for 3 hours with shaking for 5
seconds before each reading. Lipid mixing was monitored at 460 nm excitation and 538 nm
emissions wavelengths as previously described in the lipid mixing fusion assay. Content mixing
was quantified by the buildup of FRET between PhycoE-Biotin and Streptavidin-Cy5 during
content release (excitation 565 nm, emissions 675 nm). To account for increased FRET due to
vesicle leakiness and not true content mixing, replicate control wells for each of the content
mixing conditions were loaded with 4 µM free unlabeled streptavidin to bind any PhycoE-Biotin
released due to leakiness. After three hours, the plate was removed from the plate reader and 10
µL of 1% Triton X-100 was simultaneously mixed with each sample using a multi-channel
pipette. Endpoint reading were taken after Triton X-100 addition to quantify total possible
fluorescence for both content and lipid mixing assays.

Electroformation of GUV’s on Pt-Wire
All lipids used for giant unilamellar vesicle (GUV) construction were purchased from
Avanti Polar and GUV’s were formed by electroformation on platinum wire in a custom-built
chamber made in house (Figure 2a). The chamber was assembled by securing a silicone doublesided adhesive spacer (3M) to a 3” x 1” glass microscope slide and fixing the bottom well of the
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chamber to the opposite side of the adhesive spacer (Figure 2b). The glass slides were
preincubated in a solution of sterile water containing 3 mg/mL casein protein for 3 minutes and
dried overnight before applying the adhesive. All glass slides making contact with liposomal
membranes were incubated in casein to keep the GUVs from bursting when contacting shear
glass. Silicone adhesive glue (3M) was then spread completely around the edge of the chamber
to seal it from leaking during electroformation (Figure 2c).
Lipid stock solutions of 0.25-1 mg/mL were prepared for GUV formation by mixing
DOPC, ergosterol, and NBD-PE in a 4 mL glass tube with PTFE liners in a 90:9:1 molar %
concentration, respectively. All lipid solutions were prepared in a fume hood and handled with
glass syringes as the lipids are solubilized and mixed in chloroform. When applying lipid
deposits on to the platinum (Pt)-wires the lid of the electroformation chamber was placed in the
mount (Figure 2d) to keep the electrodes stable. The lipid deposits were made with 2.5 µL of the
lipid stock solution using a 5µL fixed needle Hamilton syringe with a beveled tip. For each
electrode, 3-6 lipid droplets were deposited in as thin of layers as possible and dried under a very
gentle stream of nitrogen, taking care not to disturb the droplet. The whole lid assembly
containing the Pt-wire electrodes was placed in a vacuum desiccator and the lipids were dried of
chloroform under vacuum pressure for two hours (Figure 2e).
The lipid droplets may be swelled in a variety of buffers, but for most electroformations
GUVs were swollen in 10 mM Tris buffer (pH 7.4) containing 1 mM EDTA to accord with
protein buffer conditions. The assembled bottom half of the chamber was checked for leaks and
the function generator was warmed up by allowing it to run for 30 minutes at the desired
amplitude before applying electricity to the Pt-wire electrodes. After inspection, the chamber was
filled with 1.5 mL of the desired buffer and the lid of the chamber was secured to the assembled
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bottom by screwing them together very slowly and carefully as to avoid disturbing the lipid
deposits. Once the chamber was fully assembled, it was carefully placed in the chamber rack and
the alligator clips were secured to the electrode posts making sure to be in direct contact with the
Pt-wire (Figure 2f). The entire chamber and rack assembly was placed on ice for the formation
procedure as the constant electric flow produces heat that can build pressure inside the chamber.
For low ionic swelling buffers (10 mM Tris and 1 mM EDTA), step 1 of the electroformation
was started with the amplitude at 0.5 Vpp (peak-to-peak) and hand ramped to 2 Vpp evenly over
a 30-minute time period with a constant frequency of 300 Hz using a sine wave. After thirty
minutes, the liposomes were allowed to swell (step 2) by electroformation at the same amplitude
and frequency (2 Vpp and 300 Hz) for 90 minutes. For detachment of the GUV’s from the Ptwire, the frequency was abruptly dropped from 300 Hz to 50 Hz and then gradually dropped
from 50 Hz to 2 Hz over a 30-minute period. The GUV’s were allowed to detach under a
constant amplitude of 2 Vpp and frequency of 2 Hz for an additional 30 minutes (Table 10) then
the chamber was lightly tapped to detach any GUVs still clinging to the Pt-wire. GUVs were
harvested using 1 mL large orifice pipette tips (Fisherbrand) to reduce shear force and bursting
of the liposomes when being drawn though small diameter pipette tips due to their large size (1
µm-100 µm).
To visualize the success of GUV formations, glass slides coated with casein protein were
prepared with double sided adhesive silicone spacers as previously mentioned but containing a
hole punched through the center of the spacer. The well made from the hole punch was then
filled to the top with the collected GUV solution (20-50 µL) and a cover slip secured to the
opposite side of the adhesive silicon spacer was held in place for at least 1 minute to prevent
leaking. The glass slide was then placed into an inverted spinning disk confocal microscope
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(Olympus) and the GUVs were visualized using GFP wavelengths (Figure 3). Note: for these
GUVs the premixed lipid solution contained NBD-PE (excitation/emission, ~463/536 nm), for
vesicles formed with Liss Rhod-PE (excitation/emission, ~560/583 nm) instead of NBD-PE the
GUVs should be visualized using RFP wavelengths.
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RESULTS

Endosome-to-TGN SNAREs are Required to Stimulate Lipid Mixing In Vitro
Retrograde fusion of endosome-derived vesicles with the trans-Golgi membrane requires
Tlg2, Tlg1, Vti1, and Snc2 to stimulate membrane fusion. The SNARE proteins were purified as
recombinant proteins and visualized with SDS-PAGE gel electrophoresis and Coomassie blue
staining (Figure 4). SNARE incorporation into liposomes was visually assesed using 10 µL of v
or t-proteoliposomes in 200 µL Bradford assay buffer and by western blot using v-SNARE
proteoliposomes containing Snc2p (Figure 5). Proteoliposome formations was visualized by
confocal microscopy using RFP excitation for Liss-Rhodamine labeled proteoliposomes (Figure
6). While SNARE mediated fusion resulted in increased fluorescence compared to v-SNARE
blank controls or empty liposomes, lipid mixing is modest and only accounts for ~10 % of the
total fusion potential as judged after TritonX-100 addition. The addition of Snc2-C-terminal
peptide showed only a modest increase of lipid mixing at low concentrations in preliminary
assay (Figure 7) but this could not be replicated in later assays. In all later assays Snc2-C-peptide
did not increase fusion when compared to SNARE only controls as reported in Paumet et al.,
(2001) and Paumet et al., (2004). Due to the ineffectiveness of the Snc2 C-terminal peptide in
stimulating lipid and content mixing the data were omitted from subsequent fusion assays for
clarity.

Vps1 Stimulates SNARE Mediated Endosome-to-TGN Lipid Mixing
The concentration of Vps1 used in both lipid mixing and simultaneous assays was
determined by preliminary lipid mixing trails using increasing concentrations (10 nM, 100 nM,
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and 1 µM) of Vps1 (Figure 8). Increasing concentrations of Vps1 was shown to stimulate lipid
mixing in a concentration dependent manner with the 1 µM concentration facilitating the highest
rate of lipid mixing (Figure 8). For all subsequent assays 1 µM concentrations were used as this
protein concertation was similar to the SNARE concentrations used in later fusion assays (1 µM3 µM). It is important to note that this concentration does not cause significant lipid mixing on
empty liposomes and increased lipid mixing was seen when Vps1 was added to liposomes
population that contained incorporated SNARE proteins (Figure 9b).

Vps1 May Stimulate SNARE-mediated Fusion in a Nucleotide Dependent Manner
In preliminary lipid mixing assays, there was very little difference between the rates of
fusion of SNARE proteoliposomes containing Vps1 in the presence of the three nucleotide
variants GDP, GTP, and GTgP (Figure 9a). In these assays a lower concentration of SNAREs
was used (see Table 3) as well as 10 µM of all nucleotide variants. While SNAREs and Vps1
were both shown to stimulate lipid mixing when compared to controls, there was no discernable
difference between the effects of different nucleotides on the reaction.
In later assays, the SNARE protein concertation’s were increased to roughly 1:1000
protein to lipid ratios to closer reproduce the functional concentrations being used in many of the
recently published intracellular fusion assay (Table 3). The concentration of available nucleotide
was also increased from 10 µM to 100 µM in these later assays (Figure 9b,10a,10b). After these
modifications, GTP was shown to increase fusion most substantially followed by GDP then
GTgP (Figure 9b). In these later assays, the higher concentration of SNARE proteins and
nucleotide could account for the increased lipid mixing seen with these samples (Figure
9b&10a).
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Endosome-to-TGN SNAREs Alone are not Sufficient to Facilitate Full Fusion and Content
Mixing
SNAREs alone showed significantly less lipid mixing when simultaneous reconstitution
strategies were used to reconstitute proteoliposomes compared to the previous lipid mixing
assays (Figure 10a). This may be due to the difference in reconstitution protocols as the
simultaneous assay used a direct methods of SNARE incorporation into preformed liposomes
and extended dialysis procedure (Table 9). These differences likely affect membrane
permeability as liposomes constructed by the simultaneous method were shown to have almost
no content leaking or lysis when test samples were compared with control wells containing
unlabeled streptavidin (Figure 10b). As in the previous fusion assays (Figures 8,9a,9b), Vps1
stimulated lipid mixing in the simultaneous assay more than that of SNAREs alone (Figure 10a).
Unlike the previous results that found GTP stimulated lipid mixing more than other nucleotides
in the presence of Vps1 (Figure 9b), GTgP was shown to most significantly effect lipid mixing in
the simultaneous fusion assay. While Vps1 was shown to stimulate lipid mixing in a nucleotide
dependent manner, neither SNAREs nor the addition of Vps1 and nucleotide helped to facilitate
full fusion and content mixing as no FRET signal between Cy5-Streptavidin and PhycoE-biotin
was observed until after TritonX-100 addition and solubilization of the liposomes (Figure 10b).
In the simultaneous assay, samples including Dynasore did increase FRET signal, but this is
likely due to interference from the fluorescence of Dynasore as this was witnessed in previous
trials and the increase in FRET proceeds very slowly which is uncharacteristic of content mixing
reactions.
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DISCUSSION

SNARE proteins are believed to be key components in regulating membrane fusion, but
their exact role in fusion has been extensively debated. This discussion centers on if SNAREs are
the minimal fusion machinery that mechanically drives the fusion reaction forward, or if they
serve as a scaffold to set up the reaction and allow fusion to progress. The “minimal machinery”
hypothesis proposed that cognate v- and t-SNAREs on apposed membranes are all that is
necessary to achieve sufficient membrane fusion at the most basic level (Weber et al., 1998).
This minimal model has proven inadequate to fully explain fusion as lipid mixing progresses
very slow and content mixing is generally minimal or absent. Also, excessively high SNARE
concentrations are needed to significantly increase fusion rates, and there have been
inconsistency between lipid mixing capabilities when using different intracellular SNARE
partners (Nickel et al, 1999; Wickner & Rizo, 2017; Furukawa & Mima, 2014). One of the major
challenges of interpreting the inconsistencies between reconstitution assays has been the lack of
in vivo data to support correlations of the numerous in vitro models (Chen et al, 2006). More
recent models of membrane fusion have incorporated a host of other proteins and lipids that hold
critical functions in the fusion reaction. While these models still incorporate SNARE pairing and
zippering, they also insert many other proteins (such as SMs, tethers, Sec 17/α-SNAP and/or
synaptotagmin) directly into the fusion reaction as key component that are just as essential as
SNAREs to reconstitute true fusion mechanisms (reviewed in Wickner & Rizo, 2017). In these
assays, it was shown that vacuolar fusion had tight requirement for Sec17 binding to assembled
SNAREs to further stabilize the complex. Additionally, Sec17 and synaptotagmin-1 were both
shown to insert apolar “wedge” domains into the bilayer to facilitate lipid rearrangement that
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may cause a local destabilization of the bilayer at fusion “hot spots” in the separate vacuolar and
presynaptic membrane fusion models

Homotypic Vacuolar Fusion Model
In yeast, vacuolar fusion models have shown that efficient fusion can be achieved at
physiological SNARE levels if Rab/Ypt7 protein was loaded on both membranes in the presence
of GTP (Zick & Wickner, 2016). Further studies, have also incorporated requirements for the
tether HOPS, which contain the SM protein subunit Vps33 (Baker et al, 2015), and fusogenic
lipids such as acidic lipids and phosphoinositide’s (Stroupe et al, 2006; Mima et al, 2008;
Karunakaran & Wickner, 2013; Orr et al, 2015) to recapitulate fusion at physiological SNARE
concentrations. Interestingly, Sec17, which is known to function in disassembly, was also shown
to bind SNAREs and insert its apolar N-terminal tail domain into the bilayer likely to facilitate
lipid rearrangement that may make the bilayers more prone to fuse (Zick et al, 2015). Though
results from some lipid mixing assays have shown significant lipid dequenching with SNAREs
in relatively high concentrations, when SNAREs alone were used in more stringent content
mixing assays, very little fusion was detected without the addition of the tether HOPS for
vacuolar fusion. (Zick & Wickner, 2013). In addition, high SNARE densities were shown to be
accompanied by substantial lysis when measuring content mixing meaning lipid dequenching
may likely arise from lysis and reannealing and not traditional fusion mechanisms (Zucchi and
Zick, 2011). These findings strongly support the need for a multitude of proteins localized at
active zones for fusion to accomplish every stage of the fusion reaction.
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Presynaptic Fusion Model
While the involvement of SM proteins in trans-SNARE pairing has been extensively
studied in presynaptic fusion models, novel roles for additional proteins such as synaptotagmin
and functional tethers like Munc13 are still being discovered. While vacuolar and synaptic fusion
share common features, the most striking difference is the requirement for Ca2+ and the calcium
sensor synaptotagmin to trigger neurotransmitter release (Fernandez-Chacon et al, 2001). Some
other differences that may account for mechanistic deviations are that the Qb and Qc SNARE
motifs are actually located on a single SNARE (SNAP-25) and the Qa SNARE (syntaxin-1)
adopts a closed conformation that is resistant to trans-SNARE assembly (Dulubova et al, 1999;
Misura et al., 2001). It has long been established that the closed conformation of syntaxin-1
strongly associates with the SM protein Munc18 (Dulubova et al, 1999), but more recently
Munc13’s roles in opening syntaxin-1, regulating assembly in a NSF/α-SNAP resistant manner,
and vesicle bridging and tethering have been further elucidated (Ma et al, 2011; Liu et al, 2016).
This has led researchers to propose that the multiple functions exhibited by Munc18 and Munc13
in tethering and SNARE assembly may be similar to those fulfilled by the HOPS complex.
Though these proteins are very structurally distinct (HOPS is a five-subunit complex), their
differences may allow for the multiple modes of regulation necessary for presynaptic membrane
fusion (Wickner & Rizo, 2017). As is the case for reconstituted vacuolar fusion, high densities of
neuronal SNAREs alone were needed to facilitate fusion. This likely means that the integrity of
the membrane was compromised as judged by substantial leakage and PEG was again necessary
to induce tethering (Dennison et al, 2006). Later it was found that the addition of synaptotagmin1 and Ca2+ could induce content mixing at near physiological SNARE concentration (Lai et al,
2013). More recent membrane reconstitutions containing Munc18-1, Munc13-1, NSF, α-SNAP,
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and the neuronal SNAREs showed that these proteins assembled and formed a primed state that
could readily induce lipid mixing, but little content mixing was observed without the addition of
Ca2+ in the presence of synaptotagmin-1 (Liu et al, 2016). These findings, as well as those in the
vacuolar system, support the assertion that SNAREs alone are not sufficient to complete the full
fusion reaction cycle.

Endosome-to-Golgi Fusion Model
Numerous fusion assays have been performed in the vacuolar and presynaptic systems,
but assays reconstituting endosomal fusion are seriously lacking. To date, only two published
lipid mixing assay have been employed incorporating the same endo-to-TGN yeast SNAREs
used in this study; Snc2p, Tlg2p, Tlg1p, and Vti1p (Paumet et al, 2001; Paumet et al, 2004).
Interestingly, in the previous research almost no lipid mixing was observed without the
activation of the syntaxin Qa-SNARE (Tlg2p) by a 33-amino acid Snc2 C-terminal peptide. Our
data supports their previous findings that little to no lipid mixing happens in the presence of
SNAREs alone, but we were unable to induce fusion using this Snc2 C-terminal peptide. Even
using concentrations as high as 1 mM and following the preincubation strategies suggested to
enhance the reaction rate I was unable to increase the rate of fusion more than that of SNAREs
alone. This could possibly be due to the differences in construction since the peptide used by
Paumet et al, 2001 was purified as a recombinant protein and our peptide was constructed by
synthesis. It is possible that our synthetic peptide was unable to adopt a functional secondary
structure, although structural data to elucidate the specific mechanism by which this peptide
activates the syntaxin was not included in the previous studies (Paumet et al, 2001; Paumet et al,
2004).
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Related Finding of this Study
In a systematic lipid mixing study assessing the fusogenisity of liposomes containing
variable v and t-SNARE arrangements of 14 purified yeast SNAREs involved in ER-to-Golgi,
intraGolgi, endosomal, and vacuolar fusion; a requirement for tethering factors was necessary for
endosomal and ER-Golgi SNAREs to achieve substantial lipid mixing. In those assays,
endosomal fusion was enhanced by PEG-mediated synthetic tethering, while ER-Golgi fusion
required PEG-mediated tethering as well as the addition of the resident SM protein Sly1p
(Furukawa & Mima, 2014). The SNAREs partners used in this work were very similar to the
endosomal SNAREs used in the systematic study. The only difference in the cognate SNARE
pairings being used was that the syntaxin Qa-SNAREs in this study was Tlg2p to represent endoGolgi fusion, while Furukawa and Mima, 2014 used Pep12 as the Qa-SNARE to mimic
endosomal fusion. In fact, all other SNAREs used in this study (Snc2, Tlg1, and Vti1) were
generously donated by Dr. Mima’s lab and were purified from the same plasmid constructs as
those used in their published work (Furukawa & Mima, 2014). While the syntaxin’s are
different, which may result in considerably different mechanism of activation, findings from my
study are consistent with their findings that SNAREs alone are not sufficient to facilitate
significant lipid mixing. Their research did find that endosomal lipid mixing could be stimulated
by PEG-mediated tethering, which may also be the case for endosome-to-TGN fusion.

Vps1’s Role in Membrane Fusion
The fusion assays used in my study to characterize endo-to-TGN membrane fusion are
the first to incorporate the dynamin-like protein Vps1 into multiple reconstituted in vitro fusion
assays. My research is also the first to study Vps1’s involvement in SNARE-mediated
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endosome-to-TGN fusion. In previous studies, Vps1 was proposed to facilitate vacuolar transSNARE assembly through sequestration of Qa-SNARE (Vam3) and facilitating Vam3’s
interaction with HOPS complex (Alpadi et al, 2013). Later research from the same lab also
asserted a role for Vps1 in the transition from hemifusion to content mixing in homotypic
vacuolar fusion through oligomerization of Vps1 and binding the SNARE domain of Vam3 to
increase the number of available trans-SNAREs for fusion (Kulkarni et al, 2014). While findings
from these two papers have provided novel insight supporting a role for Vps1 in vacuolar fusion
there have been no follow up studies to support these initial observations. Furthermore, an
abundance of yeast vacuolar fusion assays have been conducted with both purified yeast vacuole
and liposomes containing purified SNAREs (see Introduction and earlier Discussion) and none
of these experiments required Vps1 to recapitulate fusion. While my research does support a
nucleotide dependent role for Vps1 in lipid mixing and possible hemifusion, my results do not
support a model in which SNAREs and Vps1 alone can facilitate full fusion and content mixing.
One major difference that may account for the discrepancy in the results is that my assay did not
incorporate tethering factors such as HOPS, which was used both in the Alpadi et al, 2013 and
Kulkarni et al, 2014 assays. In addition, HOPS holds dual functions in tethering and SNARE
assembly as the SM protein (Vps33) is incorporated into the 5 subunit complex and it has been
extensively shown that HOPS facilitates both lipid and content mixing, as mentioned previously.
One other possible explanations for this discrepancy is that previous research in our lab found no
interaction between Vps1 and any of the endo-TGN SNAREs used in the reconstitutions as
judged by GST-pulldown, though a previous Yeast-2-Hybrid assay provided evidence of
interactions between Vps1 and endo-TGN SNAREs Snc2 and Vti1 (Makaraci et al, 2018). It is
possible that Vps1 tethers liposomal membranes by a mechanism that requires nucleotide
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dependent oligomerization but does not associate or has weak association with SNARE proteins
during tethering which is illustrated and discussed in the working model for Vps1 assisted
endosome-to-Golgi fusion (Figure 11). As all reconstitutions using endo-to-TGN SNAREs alone
have failed to recapitulate fusion without additional factors (Snc2-C-Pept or PEG-mediated
tethering), it is likely that the addition of tethering factors such as GARP or PEG-mediation may
help to facilitate lipid and/or content mixing.

Future Directions
While my data strongly support the role of Vps1 in increasing SNARE-mediated lipid
mixing, the fusion reaction was relatively slow and no content mixing was observable in any of
the experimental conditions. Furthermore, my research only represents initial pilot studies to
evaluate the efficiency of reconstitution techniques and assess general trends in the data to
facilitate future studies for the role of Vps1 in fusion. These future studies should increase the
sample size to include the average of three separate trials (n=3) with three technical replicates for
each sample condition being studied. Further studies should also incorporate the additional
protein factors shown to be necessary in both vacuolar and synaptic membrane fusion, mainly
tethers with associated Rab’s and SM-like proteins. Of these factors, tethering can be artificially
simulated using PEG solution as previously mentioned or by the addition of the Golgi tethering
factor GARP. The relevant endosome-to-Golgi SM protein (Vps45) may also be required for
activation of the Qa-SNARE (Tlg2) and/or trans-SNARE assembly, so preincubation of
liposomes with Vps45 may facilitate faster lipid and/or content mixing. Lastly, the lipid
compositions of the reconstituted liposomes can be further marked for specificity using PI3P and
PI4P on v- and t-liposomes to better mimic endosomal and Golgi membranes, respectively.
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Table 1: Yeast and mammalian SNARE and SM proteins for each type of fusion being discussed

Presynaptic/Plasma Membrane Fusion
Fusion Proteins
v-SNARE

Yeast
Snc1/2

Mammalian
Synaptobrevin

t-SNARE

Sso1/2, Sec9

Syntaxin1, SNAP-25,

SM-like protein

Sec1

MUNC-18

Homotypic Vacuolar Fusion
Fusion Proteins
v-SNARE

Yeast
Nyv1

Mammalian
VAMP8?

t-SNARE

Vam3, Vti1, Vam7

Syntaxin7, VTI1b, Syntaxin8?

SM-like protein

Vps33

VPS33a/b

Endosome-to-Golgi Fusion
Fusion Proteins
v-SNARE

Yeast
Snc2

Mammalian
VAMP-4

t-SNARE

Tlg2, Vti1, Tlg1

Syntaxin16, VTI1a, Syntaxin6

SM-like protein

Vps45

VPS45

47

Table 2: Lipid concentrations used for lipid mixing assay

Premixed lipids for Lipid Mixing Assay (6 mM)
Lipid Stocks

Mol%

v-SNARE lipids

Mol%

t-SNARE lipids

DOPC 18:1 (25 mg/mL)

82

30.94 µL

85

80.18 µL

DOPS 18:1 (10 mg/mL)

15

14.58 µL

15

36.45 µL

NBD-PE 18:1 (1 mg/mL)

1.5

16.63 µL

-

-

Liss Rhod-PE (1 mg/mL)

1.5

23.43 µL

-

-

Chloroform (200 µL total)

-

114.41 µL

-

83.37 µL
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Table 3: SNARE protein concentrations for lipid mixing assay

v-SNARE Liposomes
v-SNAREs

[Molar]

Initial Trials
Volumes

[Molar]

Final Assays
Volumes

Snc2p (84.88 µM)

40 nM

0.188 µL

6 µM

28.28 µL

Reconstitution Buffer w/

-

399.81 µL

-

371.72 µL

1% βOG

t-SNARE Liposomes
t-SNAREs

[Molar]

Initial Trials

[Molar]

Final Assays

Tlg2p (27.83 µM)

40 nM

0.92 µL

2 µM

46 µL

Tlg1p (12.3 µM)

40 nM

2.3 µL

2 µM

115 µL

Vti1p (13.25 µM)

40 nM

2.92 µL

2 µM

146 µL

Reconstitution Buffer w/

-

993.86 µL

-

693 µL

1% βOG
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50

A

Lane

+GTP

+Dynasore

+Vps1

+GDP

+GTg -P

+Vps1

+GTP

C-pept

C-pept

+Vps1
+t-lipo

+t-lipo

+ v-lipo

7

+Vps1

lipo

+ v-

6

+Vps1

+Snc2-

+Snc2-

+ v-lipo

5

+t-lipo

+ v-lipo

4

+t-lipo

+t-lipo

+ v-lipo

3

+t-lipo

+ v-lipo

+ v-lipo

+t-lipo

2

1

Contents of each well of 96-well plate
8

+GTP

+Vps1

+t-lipo

+ v-lipo

Table 4. Well contents of 96-well plates for lipid mixing assay and simultaneous fusion assays

+Buffer

+ v-lipo

9

+GTP

+Vps1

+ Buffer

+ v-lipo
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Table 5: Lipid concentrations for simultaneous lipid and content mixing assay

Premixed Lipids for Simultaneous Fusion Assay (5 mM)
Lipid Stocks

Mol%

v-liposome for
lipid mixing

Mol%

v-liposomes for
content mixing

Mol%

t-liposomes
used for both

DOPC 18:1 (25 mg/mL)

39

25.76 µL

40

26.42 µL

40

26.42 µL

DOPS 18:1 (10 mg/mL)

19

32.32 µL

20

34.02 µL

20

34.02 µL

DOPE 18:1 (10 mg/mL)

19

29.69 µL

20

31.25 µL

20

31.25 µL

Ergosterol (10 mg/mL)

20

16.66 µL

20

16.66 µL

20

16.66 µL

NBD-PE 18:1 (1 mg/mL)

1.5

29.11 µL

-

-

-

-

Liss Rhod-PE (1 mg/mL)

1.5

41.01 µL

-

-

-

-
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Table 6: Protein and lipid concentrations used to reconstitute v-liposome for simultaneous assay

v-SNARE Liposomes (500 µL)
v-SNAREs

Final
Concentration

Lipid mixing
volume

Final
Concentration

Content mixing
volume

Snc2p (84.88 µM)

5 µM

29.45 µL

5 µM

29.45 µL

Containing
Reconstitution Buffer

Containing
100 µL

1% βOG

100 µL
1% βOG

Premixed lipids for
2 mM

200 µL

2 mM

200 µL

170.55 µL

-

-

-

~5.5 µM

170.55 µL

Lipid/Content (5 mM)
Containing
Reconstitution Buffer
1% βOG
Cy5-Streptavidin (16
µM) w/ 1% βOG

Table 7: Concentration of t-SNAREs for overnight incubation for assembly of trans complex’s

t-SNARE Incubation (4 ◦C )
t-SNAREs
Tlg2p (27.83 µM)

Final Molar
Volumes of SNAREs (x2 for
concentrations content & lipid mixing assays)
1 µM
53.9 µL

Tlg1p (12.3 µM)

1 µM

89.32 µL

Vti1p (13.25µM)

1 µM

113.2 µL

Reconstitution Buffer

-

92 µL
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Table 8: Protein and lipid concentrations used to reconstitute t-liposome for simultaneous assay

t-SNARE Liposomes (500 µL)
v-SNAREs

Final
Concentration

Lipid mixing
volume

Incubated w/
Assembled t-SNAREs

Final
Concentration

Content mixing
volume

Incubated w/
174.2 µL

1% βOG

174.2 µL
1% βOG

Premixed lipids for
2 mM

200 µL

2 mM

200 µL

20% βOG

~1%

6 µL

~1%

6 µL

Reconstitution Buffer

1% βOG

119.8 µL

-

-

-

-

4 µM

119.8 µL

t-liposomes (5 mM)

PychoE-Biotin (16.7 µM)
w/ 1% βOG
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Table 9: Dialysis times and conditions for simultaneous fusion assay

Simultaneous Assay Dialysis
Buffer Volume

SM-2 Bead

Time

Temperature

1st run

0.5 L

1g

1hr

Room temp.

2nd run

0.5 L

1g

2hr

4 ◦C

Final run

1L

2g

~16hr

4 ◦C

Table 10: Electroformation conditions using function generator

Pt-wire GUV Electroformation
Steps

Vpp

Frequency (Hz)

Time

1

1à2V

300

1hr

2

2V

300

2hr

3

2V

50 à 2

30min, 30min

54

Figure 1: Liposome separations after ultracentrifugation with Nycodenz floatation gradient. The
simultaneous fusion assay has the advantage of making vesicle separation layers clearly visible
due to the used of multiple fluorescent molecules. The florescent content and assay used for each
of the liposomes are in ordered from left to right as shown; Cy5-Streptavidin incorporated into tliposomes for the content mixing, PhycoE-biotin incorporated into v-liposomes for content
mixing, Liss-Rhodamine PE lipids (quenching NBD-PE) used to reconstitute v-liposomes for
lipid mixing. No florescent labels were used to create t-liposomes for the lipid mixing assay (far
right) as mixing is measured by the dequenching of NBD florescence from Liss-Rhodamine
upon fluorophore dilution on unlabeled membranes.
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A

B

C

D

E

F

Figure 2. Pt-wire electroformation chamber assembly procedures. The electroformation chamber
was assembled as discussed in the Methods section.
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Figure 3: Picture of GUVs formed by electroformation on Pt-wire. The GUV’s were formed by
electroformation on Pt-wire and visualized using confocal microscopy as discussed in the
Methods section.
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Figure 4: Yeast endo-to-Golgi fusion protein used in this study. Proteins were visualized after
Coomassie blue staining using and HP laser jet scanner (purple images) or with an Azure Cseries advanced imaging system (black and white images). Proteins from left to right are as
follows; His-Vps1p (79 kDa), His-Tlgp1 (26.5 kDa), His-Vti1p (26.5 kDa), His-Snc2 (24 kDa),
GST-Tlg2p (70 kDa)
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20kDà
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Figure 5: Confirmation of v-SNARE incorporation into proteoliposomes. V-liposomes were
solubilized in 1xPBS containing SDS and the proteins incorporated into the proteoliposome were
separated using SDS-PAGE gel electrophoresis. Western blot analysis and anti-His antibodies
were used to confirm the presences of His-Snc2p (14kD after cleavage). The smearing is likely
due to lipid contaminations from the liposomes, which should be previously solubilized with 1%
Triton X-100 before protein clarification by centrifugation.

Figure 6: Visualization of liposome formation with confocal microscopy. Liposomes were
loaded into wells prepared on glass slides and visualize using confocal microscopy with
simultaneous RFP and GFP excitation and emissions. The above figure shows the multi-view of
each wavelength from left to right; GFP, RFP, both GFP and RFP. Liposomes should only be
visible when excited with RFP lasers as Liss Rhodamine-PE will quench the emission of NBDPE excited by GFP wavelengths. See figure 3 for an example of GUV’s prepared with NBD-PE
alone and visualized using GFP wavelengths.
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Effects of Increasing Snc2-C-Peptide on Lipid Mixing
128

NBD Flourescence (RFU)

123

118

113

108

103

98
Snc2-C-pept. (.2µL)

Snc2-C-Pept. (2µL)

Snc2-C-pept. (10µL)

Figure 7: Effects of increasing Snc2-C-terminal peptide concentrations on endo-to-TGN
liposome fusion. Proteoliposomes for lipid mixing were prepared as described in the methods
with the protein concentration used for “Initial Trial Volumes” (Table 3). All wells were
prepared with 5 µL v-liposomes and 45 µL t-liposome and incubated with above concentrations
of Snc2-C-terminal peptide for 2 hours at 4 ◦C before the fusion reaction was started. Lipid
mixing assays were monitored by dequenching of NBD-PE from Liss Rhod-PE (excitation
460nm emission 538 nm) for 2 hours
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Effects of increasing concentrations of Vps1
on Lipid Mixing
129

NBD Flourescence (RFU)

124

119

114

109

104

99

94

v-lipo+buffer
SNAREs+Vps1 (100nM)

SNAREs+Vps1 (10 nM)
SNAREs+Vps1 (1 µM)

Figure 8: Effects of increasing Vps1 concentration on endosome-to-Golgi fusion.
Proteoliposomes for lipid mixing were prepared as described in the methods with the protein
concentration used for “Initial Trial Volumes” (Table 3). All wells were prepared with 5 µL vliposomes, 45 µL t-liposome, and 10 µM GTP then incubated 2 hours at 4 ◦C before the addition
of Vps1p to start the reaction. Lipid mixing assays were monitored by dequenching of NBD-PE
from Liss Rhod-PE (excitation 460nm emission 538 nm) for 2 hours. The increasing
concentrations of Vps1 was shown to positively stimulate lipid mixing and 1 µM concentrations
were used in all subsequent assays as explained in Results.
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Effect of Vps1 and Nucleotide on SNARE-mediated Lipid
Mixing

NBD Flourescence (RFU)

150
140
130
120
110
100
90
SNAREs Only

Vps1

Vps+GDP

Vps1+GTỿP

Vps1+GTP

v-lipo only + Buffer

Figure 9a: Effect of Vps1 and nucleotide on assisted lipid mixing. Proteoliposomes for lipid
mixing were prepared as described in the methods with the protein concentration used for “Initial
Trial Volumes” (Table 3). Control wells were prepared with 5 µL of fluorescent v-liposomes and
reconstitution buffer lacking the prepared t-liposomes (v-lipo only). All other wells were
prepared with 5 µL v-liposomes and 45 µL t-liposome as in SNAREs only and Vps1 and
nucleotide was added to test samples as shown in the figure legend and Table 4. Lipid mixing
assays were monitored by dequenching of NBD-PE from Liss Rhod-PE (excitation 460nm
emission 538 nm) for 2 hours
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Effects of Vps1 and Nucleotide on SNARE-mediated Lipid
Mixing
112.5

NBD Flourescence (RFU)

107.5

102.5

97.5

92.5

87.5
SNAREs

Vps1

Vps1+GDP

Vps1+GTP

Empty lipo

Empty+Vps1

Vps1+GTỿP

Figure 9b: Effects of Vps1 and nucleotide on assisted lipid mixing. Proteoliposomes for lipid
mixing were prepared as described in the methods with the protein concentration used for “Final
Assay Volumes” (Table 3). Control wells were prepared with 5 µL of fluorescent v-liposomes
and 45 µL of t-liposomes lacking the incorporated t-SNARE complexes (Empty lipo). All other
wells were prepared with 5 µL v-liposomes and 45 µL t-liposome as in SNAREs only and Vps1
and nucleotide was added to test samples as described in the figure legend and Table 4. Lipid
mixing assay monitored by dequenching of NBD-PE from Liss Rhod-PE (excitation 460nm
emission 538 nm) for 2 hours

63

Effects of Vps1 on Simultaneous Lipid Mixing
Assay
122

NBD Flourescence (RFU)

117

112

107

102

97
v-lipo+ Buffer

SNAREs only lipo

Vps1

Vps1+GTyP

Vps1+GTP

Vps1+GTP+Dynasore

Figure 10a: Simultaneous assay of lipid mixing in the presence of Vps1 and nucleotide.
Proteoliposomes for simultaneous lipid mixing were prepared as described in the methods with
the protein concentration shown in Table 6 and Table 7. Control wells were prepared with 5 µL
of fluorescent v-liposomes and 60 µL of reconstitution buffer. All other wells were prepared with
5 µL v-liposomes and 45 µL t-liposome as in SNAREs only lipo. Vps1 and nucleotide was added
to test samples as described in the figure legend and Table 4. Lipid mixing assay monitored by
dequenching of NBD-PE from Liss Rhod-PE (excitation 460nm emission 538 nm) for 3 hours
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Effects of Vps1 on Simultaneous Content
Mixing Assay
195

FRET Flourescence (RFU)

175

155

135

115

95
v-lipo+ Buffer

SNAREs only lipo

Vps1

Vps1+GTyP

Vps1+GTP

Vps1+GTP+Dynasore

Figure 10b: Simultaneous assay of content mixing in the presence of Vps1 and nucleotide.
Proteoliposomes for simultaneous content mixing were prepared as described in the methods
with the protein concentration shown in Table 6 and Table 7. Control wells were prepared with 5
µL of fluorescent v-liposomes and 60 µL of reconstitution buffer. All other wells were prepared
with 5 µL v-liposomes and 45 µL t-liposome as in SNAREs only lipo. Vps1 and nucleotide was
added to test samples as described in the figure legend and Table 4. Content mixing monitored
by increased FRET between Cy5-Streptavidin and PhycoE-Biotin (excitation 565 nm, emissions
675 nm) for 3 hours.
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Endosomal SV
Endosomal SV

Endosomal SV

D
Endosomal SV

trans-Golgi Membrane

trans-Golgi Membrane

trans-Golgi Membrane

Vps1 monomer
Vps1 oligomerized

Tlg2

Snc2

Vti1

Tlg1

trans-Golgi Membrane

Figure 11: Model of Vps1 stimulated endosome-to-Golgi SNARE-mediated fusion. A)
Endosome-to-Golgi fusion may require tethering factors, as SNAREs alone do not facilitate
significant lipid mixing in vitro B) Vps1 may facilitate SNARE-mediated fusion by binding vSNARE (Snc2) and t-SNARE (Vti1) in the monomer or oligomerized conformation of Vps1 as
previous Y2H have shown interaction between Vps1 and both of these SNARE proteins
(Makaraci et al., 2018). In this sense, Vps1 may act as a bridge between v- and t-SNAREs to
facilitate trans-SNARE complex assembly and later fusion. C) Conversely, Vps1 may facilitate
tethering by directly associating with the liposomal membranes without interacting with the
SNARE proteins during trans-SNARE assembly. Since the addition of nucleotide was shown to
positively enhance fusion, oligomerization of Vps1 may facilitate long range tethering to bring
the liposomes into close enough proximity for trans-SNARE assembly and eventual zippering
and fusion (D).
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